Overview

DexCare focuses on enhancing patient care discovery in the healthcare sector. Its platform helps match patients with appropriate healthcare providers efficiently, aiming to reduce wait times and improve the patient-clinician experience. By partnering with health systems across the U.S., DexCare's technology allows for flexible patient access across various care settings. The platform has demonstrated effectiveness, with case studies indicating a 30% increase in new patient acquisition for its partners. Unlike many competitors, DexCare emphasizes a mission-driven approach that values diversity, equity, and inclusion, while also promoting a flexible remote work culture for its employees. The company's goal is to streamline healthcare access and improve overall patient care.

Simplify's Take

What believers are saying

• DexCare closed a $75M Series C funding round for market expansion.
• The platform has surpassed 3 million scheduled visits, improving patient demand management.
• DexCare's recognition as a 'Fierce 15' company highlights its innovative market position.

What critics are saying

• Increased competition from companies like Google and Mayo Clinic.
• The acquisition of Womp may divert focus from DexCare's core healthcare platform.
• Rapid expansion may strain DexCare's operational capabilities, risking service delivery issues.

What makes DexCare unique

• DexCare transforms patient-provider relationships into scalable digital experiences.
• The platform increases revenue from digital-first patients while reducing acquisition costs.
• DexCare's platform flexibly matches patient access across care settings.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$145M

Above

Industry Average

Funded Over

3 Rounds

$75,000,000

Series C

Jun 2023

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.

Series C Funding Comparison

Above Average

Industry standards

Ind Avg. $50M

$16M

$40M

$50M

$62M

$75M

$100M

View all funding stages